Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Gross Margin (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Gross Margin for 17 consecutive years, with 67.23% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 622.0% to 67.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 71.08% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 71.08% for FY2025, 0.0% changed from the prior year.
  • Gross Margin for Q4 2025 was 67.23% at Bristol Myers Squibb, down from 71.89% in the prior quarter.
  • The five-year high for Gross Margin was 80.34% in Q4 2021, with the low at 61.01% in Q4 2024.
  • Average Gross Margin over 5 years is 75.02%, with a median of 75.69% recorded in 2023.
  • The sharpest move saw Gross Margin soared 831bps in 2021, then crashed -1507bps in 2024.
  • Over 5 years, Gross Margin stood at 80.34% in 2021, then decreased by -4bps to 77.27% in 2022, then decreased by -2bps to 76.08% in 2023, then fell by -20bps to 61.01% in 2024, then grew by 10bps to 67.23% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 67.23%, 71.89%, and 72.52% for Q4 2025, Q3 2025, and Q2 2025 respectively.